Gene expression analysis showed that the expression of MAPK8, CTNNB1, NFKB1, EGFR, CXCL8, CCL2, BCL2, and NFE2L2 increased or decreased in the hippocampus of patients with AD. This evidence concerns the gene BCL2 and Alzheimer disease.